These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20444197)

  • 41. Sex-Determining Region Y Chromosome-Related High-Mobility-Group Box 10 in Cancer: A Potential Therapeutic Target.
    Yu L; Peng F; Dong X; Chen Y; Sun D; Jiang S; Deng C
    Front Cell Dev Biol; 2020; 8():564740. PubMed ID: 33344444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different Sources of Allelic Variation Drove Repeated Color Pattern Divergence in Cichlid Fishes.
    Urban S; Nater A; Meyer A; Kratochwil CF
    Mol Biol Evol; 2021 Jan; 38(2):465-477. PubMed ID: 32941629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Down-regulation of exosomal miR-200c derived from keratinocytes in vitiligo lesions suppresses melanogenesis.
    Zhao C; Wang D; Wang X; Mao Y; Xu Z; Sun Y; Mei X; Song J; Shi W
    J Cell Mol Med; 2020 Oct; 24(20):12164-12175. PubMed ID: 32918341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sox10 Is a Specific Biomarker for Neural Crest Stem Cells in Immunohistochemical Staining in Wistar Rats.
    Yang LN; Huang WK; Li XL; Bai YZ; Zhang SC
    Dis Markers; 2020; 2020():8893703. PubMed ID: 32908618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insights into Differentiation of Melanocytes from Human Stem Cells and Their Relevance for Melanoma Treatment.
    Mirea MA; Eckensperger S; Hengstschläger M; Mikula M
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. UP256 Inhibits Hyperpigmentation by Tyrosinase Expression/Dendrite Formation via Rho-Dependent Signaling and by Primary Cilium Formation in Melanocytes.
    Kang MC; Lee JW; Lee TH; Subedi L; Wahedi HM; Do SG; Shin E; Moon EY; Kim SY
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of prdm1a accelerates melanoma onset and progression.
    Iwanaga R; Truong BT; Hsu JY; Lambert KA; Vyas R; Orlicky D; Shellman YG; Tan AC; Ceol C; Artinger KB
    Mol Carcinog; 2020 Sep; 59(9):1052-1063. PubMed ID: 32562448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A copy number variant is associated with a spectrum of pigmentation patterns in the rock pigeon (Columba livia).
    Bruders R; Van Hollebeke H; Osborne EJ; Kronenberg Z; Maclary E; Yandell M; Shapiro MD
    PLoS Genet; 2020 May; 16(5):e1008274. PubMed ID: 32433666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Height, nevus count, and risk of cutaneous malignant melanoma: Results from 2 large cohorts of US women.
    Li X; Kraft P; De Vivo I; Giovannucci E; Liang L; Nan H
    J Am Acad Dermatol; 2020 Oct; 83(4):1049-1056. PubMed ID: 32376423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Review of the Molecular Pathways Involved in Resistance to BRAF Inhibitors in Patients with Advanced-Stage Melanoma.
    Tian Y; Guo W
    Med Sci Monit; 2020 Apr; 26():e920957. PubMed ID: 32273491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic and genomic studies of pathogenic EXOSC2 mutations in the newly described disease SHRF implicate the autophagy pathway in disease pathogenesis.
    Yang X; Bayat V; DiDonato N; Zhao Y; Zarnegar B; Siprashvili Z; Lopez-Pajares V; Sun T; Tao S; Li C; Rump A; Khavari P; Lu B
    Hum Mol Genet; 2020 Mar; 29(4):541-553. PubMed ID: 31628467
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Hu J; Li K; Li Z; Gao C; Guo F; Wang Y; Xue F
    Cancer Biol Med; 2019 Aug; 16(3):462-474. PubMed ID: 31565477
    [No Abstract]   [Full Text] [Related]  

  • 53. Butterfly Mimicry Polymorphisms Highlight Phylogenetic Limits of Gene Reuse in the Evolution of Diverse Adaptations.
    VanKuren NW; Massardo D; Nallu S; Kronforst MR
    Mol Biol Evol; 2019 Dec; 36(12):2842-2853. PubMed ID: 31504750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma.
    Saei A; Eichhorn PJA
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31416288
    [No Abstract]   [Full Text] [Related]  

  • 55. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
    Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
    Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The SOXE transcription factors-SOX8, SOX9 and SOX10-share a bi-partite transactivation mechanism.
    Haseeb A; Lefebvre V
    Nucleic Acids Res; 2019 Jul; 47(13):6917-6931. PubMed ID: 31194875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MITF-the first 25 years.
    Goding CR; Arnheiter H
    Genes Dev; 2019 Aug; 33(15-16):983-1007. PubMed ID: 31123060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nuclear Entry of CRTC1 as Druggable Target of Acquired Pigmentary Disorder.
    Yun CY; Hong SD; Lee YH; Lee J; Jung DE; Kim GH; Kim SH; Jung JK; Kim KH; Lee H; Hong JT; Han SB; Kim Y
    Theranostics; 2019; 9(3):646-660. PubMed ID: 30809299
    [No Abstract]   [Full Text] [Related]  

  • 59. SOX9 is a dose-dependent metastatic fate determinant in melanoma.
    Yang X; Liang R; Liu C; Liu JA; Cheung MPL; Liu X; Man OY; Guan XY; Lung HL; Cheung M
    J Exp Clin Cancer Res; 2019 Jan; 38(1):17. PubMed ID: 30642390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The b-HLH transcription factor Hes3 participates in neural plate border formation by interfering with Wnt/β-catenin signaling.
    Hong CS; Saint-Jeannet JP
    Dev Biol; 2018 Oct; 442(1):162-172. PubMed ID: 30016640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.